Oramed Pharmaceuticals Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ORMP research report →
About the company
Oramed Pharmaceuticals Inc. , founded in 2002 and based in New York, New York, specializes in the development of groundbreaking pharmaceutical treatments. Their primary focus is on creating orally ingested capsules or pills for the delivery of polypeptides, particularly aimed at managing diabetes.
- CEO
- Nadav Kidron
- IPO
- 2007
- Employees
- 13
- HQ
- New York City, NY, US
Price Chart
- Market Cap
- $188.26M
- P/E
- 1.74
- P/S
- 0.00
- P/B
- 0.79
- EV/EBITDA
- 2.23
- Div Yield
- 5.43%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 55.29%
- ROIC
- -4.60%
- Revenue
- $2.00M · 0.00%
- Net Income
- $64.05M · 435.29%
- EPS
- $1.53 · 425.53%
- Op Income
- $-15,088,000
- FCF YoY
- -31.41%
- 52W High
- $5.19
- 52W Low
- $1.98
- 50D MA
- $4.10
- 200D MA
- $3.27
- Beta
- 1.24
- Avg Volume
- 281.98K
Get TickerSpark's AI analysis on ORMP
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jul 2, 26 | Hexter Joshua | other | 50,000 |
| Jul 1, 26 | Hexter Joshua | sell | 137,000 |
| Jul 2, 26 | Hexter Joshua | other | 50,000 |
| Jul 1, 26 | Gabay Avraham | sell | 73,360 |
| Mar 30, 26 | KIDRON NADAV | other | 44,818 |
| Mar 30, 26 | Kidron Miriam | other | 435,084 |
| Mar 17, 26 | Kidron Miriam | other | 119,558 |
| Mar 17, 26 | KIDRON NADAV | other | 167,005 |
| Mar 17, 26 | Hexter Joshua | other | 95,889 |
| Mar 17, 26 | Gabay Avraham | other | 95,889 |
Our ORMP coverage
Recent articles, reports, and earnings notes.
No research on ORMP yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate ORMP report →Similar companies
Peers in the same neighborhood.